Fidelity Value Factor ETF (FVAL)
FVAL cuts straight to the point: it screens U.S. stocks for cheap prices relative to their earnings, book value, and cash flow, then holds the basket with equal weight. No narrative, no story about management or competitive position. Just the numbers. A stock trading at six times book value, with a 4 percent dividend yield and depressed earnings, lands in the fund. A richly priced tech company trading at fifty times earnings does not.
The value factor has a long history in markets. Studies dating back decades show that stocks trading at low valuations — as measured by price-to-earnings, price-to-book, or similar metrics — have outperformed expensive stocks over long time horizons. The intuition is straightforward: if you buy something cheap and hold it long enough, either the market reprices it upward (realizing the bargain) or the company improves its earnings and the multiple remains constant (intrinsic value rises). Value has not worked in every calendar year — the tech boom of the 1990s and the 2010s saw growth and momentum crush value for a time — but over full market cycles, the value premium has generally persisted.
FVAL bets on that long-term edge. It holds a broad, diversified basket of value-screened stocks — financials, industrials, energy, healthcare, materials, consumer staples — almost anywhere in the market where valuation metrics are attractive. The equal-weight structure (each position gets roughly the same dollar amount) tilts the fund toward smaller stocks within the value universe, since a cap-weighted approach would concentrate holdings in the largest, often more defensive value names.
The composition is highly cyclical. When the economy is healthy and investors are confident, value stocks trend cheaper and growth trends richer. The opposite happens in downturns: investors get scared, abandon the expensive growth names, and rotate into cheap, high-yielding value stocks, temporarily boosting their relative performance. A value factor fund is therefore a bet not just on the long-term premium but on whether you are buying at a point in the cycle where that premium is likely to narrow (benefit you) or widen (hurt you).
The holdings are transparent and rules-based. There is no manager deciding that one “undervalued” financier has better prospects than another. The screening algorithm applies the same criteria to every stock, so the fund looks different from a traditional value mutual fund where a manager uses judgment. Turnover happens when stocks become expensive (leave the value screen), or when new cheap stocks enter, which typically leads to moderate annual portfolio churn.
Dividend yield in a value-oriented portfolio tends to be substantially above the market average. Many value stocks are mature, profitable companies returning capital to shareholders through dividends. FVAL distributes that income regularly, often quarterly, making it useful for income-focused investors. The fund’s expense ratio is low, a standard for Fidelity factor-oriented ETFs, meaning minimal drag on the underlying value premium.
The risks are concentrated and style-dependent. A value fund is underweighted in growth, so it will underperform during periods when growth dominates — which can last years. If the economy enters a prolonged slowdown and value stocks’ earnings compress, the fund falls alongside the broader market. Sector concentration is real: value screens tend to pull in energy, financials, industrials, and materials, sectors that are themselves cyclical and sensitive to economic conditions. You are not owning a stable, defensive portfolio; you are betting on value mean reversion within a structure likely to move sharply when the economic cycle turns.
The equal-weight structure also introduces volatility. Smaller stocks within the value screen tend to be more volatile than large-caps, so FVAL swings more than a cap-weighted value approach would. The rebalancing to equal weight — periodically trimming winners and buying losers — creates some drag during strong up markets (you are mechanically selling strength) and provides some benefit during downturns (you are buying weakness). Over long cycles, that rebalancing benefit has added value, but it is not guaranteed.
FVAL suits disciplined, long-term investors comfortable with factor-based, rules-driven approaches. It works well as a core holding in a diversified stock portfolio, paired with growth exposure, and as a way to get pure factor exposure without manager judgment. Someone convinced the value premium will persist and who has the patience to hold through lengthy periods of underperformance can use FVAL as the backbone of their stock allocation.
For research: pull the current holdings and sector breakdown. Note the valuation metrics of a few positions and verify they match the value screen. Compare FVAL’s rolling three-year, five-year, and ten-year returns to the broad market and to other value offerings, and ask yourself honestly whether you can tolerate the drawdowns and periods of underperformance that come with pure factor exposure. Monitor the size of the value premium — if valuations compress to historic extremes, the opportunity may be exhausted. Track whether the stocks in the fund are producing the earnings growth management expects, since a value trap (a cheap stock that stays cheap because earnings are permanently impaired) is the main way value investing fails.